Introduction
IVF treatment is well established in the contemporary management of infertility and currently accounts for 1% of the total births in the UK. 1 Due to the practice of transferring more than one embryo to maximise the chance of pregnancy, the incidence of multiple pregnancy after IVF treatment has risen to over 25%, nearly 20 times higher than would be expected after spontaneous conception. 2 Compared with singletons, twins have a seven-fold increase in neonatal mortality and six-fold increase in the risk of cerebral palsy. 3 Maternal morbidity and mortality rates and costs to the health service are also increased. [3] [4] [5] [6] As a result, multiple pregnancy is now considered the single most important risk of IVF treatment. [7] [8] [9] It has been recognised that the only effective method to reduce the multiple pregnancy rate (MPR) after IVF is to adopt a policy of single embryo transfer (SET). [10] [11] [12] [13] An expert panel commissioned by the Human Fertilisation and Embryology Authority in 2005 to review the evidence on multiple births and SET proposed that IVF clinics should develop criteria for selecting groups of women who should be offered SET. 10 However, guidance on how to implement this policy or its potential effect on a clinic's overall results was not provided.
A potential risk to implementation of an SET policy is the decline in pregnancy rate per IVF cycle started. 14, 15 A Cochrane Review published in 2004 15 showed that transfer of a single cleavage-stage (day 2 or 3) embryo versus two cleavage-stage embryos resulted in a reduction in the MPR (risk ratio [RR] 0.12, 95% CI 0.03-0.43, P = 0.0008), but with a concurrent reduction in the clinical pregnancy rate (CPR) (RR 0.68, 95% CI 0.52-0.9, P = 0.006).
Recent evidence suggests that transfer of a single blastocyst on day 5 of in vitro culture is associated with a higher CPR compared with transfer of a single cleavage-stage embryo. 16 Extension of culture until day 5 aids the identification of those embryos likely to have the highest implantation and pregnancy potential. 17 These two studies, 16, 17 however, were restricted to a highly selected group of women with good prognosis, whereas the wider implications of adopting this policy on the overall results in an IVF programme have not been studied. 18, 19 In this study, we aimed to examine the impact of implementing a single blastocyst transfer (SBT) strategy in a selected group of women with good prognosis on the effectiveness of a large IVF programme. We hypothesised that the CPR would be maintained and the MPR would be significantly reduced.
Materials and methods
The study was conducted at the Assisted Conception Unit at Guy's and St Thomas' Hospital; a tertiary referral centre performing around 1000 IVF and intracytoplasmic sperm injection (ICSI) cycles per year.
Study population
Between July 2004 and June 2007, all IVF/ICSI cycles performed in our unit were included. These cycles were divided into two groups-July 2004 to December 2005 (n = 1198) and January 2006 to June 2007 (n = 1253)-based on the embryo culture and transfer strategy during each period. Cycles involving preimplantation genetic diagnosis or the use of donated oocytes or cryopreserved embryos were excluded. Each couple gave written informed consent to the use of their data for analysis upon entering our IVF programme.
Ovarian stimulation and IVF/ICSI
Our protocol for ovarian stimulation has been described elsewhere. 20 Human chorionic gonadotrophin (hCG) 6500 iu (Ovitrelle; Serono Ltd, Middlesex, UK) was administered to induce oocyte maturation when at least three follicles had reached a mean diameter of ‡18 mm. Transvaginal oocyte retrieval was carried out 35-36 hours later using an ultrasound scanner with a 6.5 MHz probe (Hitachi EUB 525; Hitachi, Tokyo, Japan).
For IVF cycles, oocytes were examined for evidence of normal fertilisation [16] [17] [18] 21, 22 on day 3 were offered extended embryo culture until day 5 to allow further development of these embryos and transfer of a single blastocyst if a high-quality blastocyst 17 was present. We continued to offer transfer of up to three embryos for women where the cohort of embryos did not satisfy these criteria. Apart from the introduction of extended embryo culture and SBT for the women with good prognosis, no other changes in our clinical protocols took place.
All women who underwent embryo transfer received supplemental progesterone pessaries (Cyclogest; Shire Pharmaceuticals Ltd, Hants, UK) 400 mg daily throughout the luteal phase and until 8 weeks of gestation if pregnancy occurred.
Patient education
To allow for the successful implementation of the SBT strategy, audiovisual and written educational information regarding the risks of multiple pregnancy and advantages of SBT was given to all women at a monthly patient information seminar as well as during one to one consultations. The rationale behind our strategy was also displayed on a wall poster located in the participants' waiting area, together with regularly updated results. Women who were eligible for extended embryo culture and SBT were contacted on day 3 of culture to ensure they understood their options and to discuss any remaining concerns they might have.
Outcome measures
The study outcome measures were the CPR per cycle started and MPR per clinical pregnancy achieved. Pregnancy was confirmed by a positive urine hCG test 16 days after oocyte retrieval. A clinical pregnancy was defined as the presence of fetal heart activity detected by ultrasound 3 weeks after the positive pregnancy test. Implantation rate was defined as the number of gestational sacs observed on ultrasound scanning divided by the number of embryos transferred. 
Statistical analysis
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Discussion
The goal of any fertility treatment should be the birth of a healthy singleton infant. 10 Although the effectiveness of SET in reducing the MPR after IVF has been demonstrated, [11] [12] [13] the main challenge is to achieve this reduction while maintaining the overall success rate within the entire IVF programme.
Women with good prognosis, defined in our study as those who have at least four 8-cell embryos with less than 10% cytoplasmic fragmentation, not only have the best chance of producing blastocysts on day 5 of culture but are also at greatest risk of multiple pregnancy if two embryos are transferred. 13, 23 Extension of embryo culture till day 5 aids the identification and selection of those embryos most likely to implant. As a result, a high pregnancy rate might be expected after transferring a single blastocyst. 16 To our knowledge, this is the first study to examine the effects of applying an SBT strategy in a selected group of good prognosis women on the overall results of a large IVF programme. We compared the CPR per cycle started and the MPR per clinical pregnancy achieved during an 18-month period before and after introduction of the SBT service in our IVF programme. The objective from introducing this service was to significantly reduce the MPR by at least one-third, 5 thereby reducing the morbidity and mortality of babies and mothers.
The present study provides evidence that education and appropriate selection of participants can achieve a reduction in the MPR by almost 50% without compromising the effectiveness of the IVF programme. In fact, we observed an increase in the CPR after introduction of the SBT service despite an increase in women's mean age and basal folliclestimulating hormone level, mainly due to identification of embryos with the highest implantation potential through extended culture. 16, 17 The increase in the CPR attests to the significant potential of elective SBT to reduce the risk of multiple pregnancy when applied judiciously. Although only one in 11 (118/1253) cycles started in 2006/2007 had an elective SBT, a dramatic reduction in the MPR was achieved since only cycles at high risk of multiple pregnancy were selected.
Our data should, therefore, encourage other IVF programmes to develop similar strategies to lower their MPR without fear of reduction in their IVF success rates. This reassurance is particularly relevant in countries where the majority of IVF treatment cycles are not state funded, mounting more pressure on the treating physician to maximise each patient's chance of pregnancy per cycle. [24] [25] [26] [27] Only 19% of cycles reaching embryo transfer satisfied our eligibility criteria for extended culture and blastocyst transfer. In the next phase of our strategy to further reduce the MPR, we intend to offer extended culture and SBT in more cycles, by including those with three (rather than four) 8-cell cleavage-stage embryos with less than 10% cytoplasmic fragmentation on day 3 of culture. Other clinics need to examine their patient's characteristics and laboratory performance and modify their selection criteria accordingly. 24 Our experience could also pave the way for the development of agreed national guidelines for SET, similar to those already in place in several European countries. 28 Another advantage to this strategy is the increase in the proportion of cycles where supernumerary embryos are available for cryopreservation. By replacing fewer embryos, and at a stage where quality is deemed to be better, it is likely that a larger proportion of cycles would have surplus embryos suitable for cryopreservation. In our study, the percentage of cycles achieving embryo cryopreservation increased by 30% (from 22 to 28%) after introducing the SBT service, thereby maximising the cumulative chance of pregnancy from a single cycle of ovarian stimulation and oocyte retrieval. 12 The presence of a successful blastocyst freezing-thawing programme would further encourage women to choose the option of SBT and cryopreserve supernumerary embryos. 26, 29 Finally, patient acceptability is central to the success of any treatment modality. 30 There is evidence that multiple pregnancy is a frequently desired outcome of treatment by infertile women. 31, 32 It was therefore critical in our strategy to ensure that women are fully informed about the benefits of SBT and risks of twin pregnancy and to promote a safe practice of SET. Audiovisual and written information was disseminated to our women for this purpose, leading to sustained increase in patient acceptability to the SBT policy in 2006/2007. This paradigm shift in acceptance of SET concurs with recent research highlighting the importance of couples' education in changing their attitude towards what is regarded as a desired IVF treatment outcome. 33 In conclusion, introducing an SBT service aimed at women with good prognosis has enabled us to almost half the MPR and improved the overall efficiency of the entire IVF programme. The key elements behind the success of this strategy were selection and education of women at high risk of multiple pregnancy. j
